Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Balwani

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Expert Review of Gastroenterology & Hepatology|August 5, 2022
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiranPaolo Ventura, Eliane Sardh, Nicola Longo, et al.
Lancet (London, England)|March 31, 2015
Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trialTimothy M Cox, Guillermo Drelichman, Renata Cravo, et al.
Molecular Genetics and Metabolism|August 10, 2019
Results of a pilot study of isoniazid in patients with erythropoietic protoporphyriaCharles J Parker, Robert J Desnick, Montgomery D Bissel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 18, 2024
Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher DiseaseMary Kate LoPiccolo, Zerui Wang, Gadi Maayan Eshed, et al.
American Journal of Hematology|April 30, 2024
Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher RegistryPramod K Mistry, Manisha Balwani, Joel Charrow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2021
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's DiseaseMatthew Surface, Manisha Balwani, Cheryl Waters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2025
A Prospective, Blinded Study of Symptom Prevalence and Specificity of Porphyrin Precursors in Carriers of Acute Hepatic PorphyriaMohsen Merati, Nanditha Jayakumar, Yuvraaj Kapoor, et al.
Journal of Inherited Metabolic Disease|November 25, 2010
Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327RAlev Hasanoglu, Manisha Balwani, Ciğdem S Kasapkara, et al.
JIMD Reports|November 20, 2019
Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X-linked protoporphyriaHetanshi Naik, Jessica R Overbey, Robert J Desnick, et al.
JAMA Dermatology|June 15, 2017
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked ProtoporphyriaManisha Balwani, Hetanshi Naik, Karl E Anderson, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Expert Review of Gastroenterology & Hepatology|August 5, 2022
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiranPaolo Ventura, Eliane Sardh, Nicola Longo, et al.
Lancet (London, England)|March 31, 2015
Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trialTimothy M Cox, Guillermo Drelichman, Renata Cravo, et al.
Molecular Genetics and Metabolism|August 10, 2019
Results of a pilot study of isoniazid in patients with erythropoietic protoporphyriaCharles J Parker, Robert J Desnick, Montgomery D Bissel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 18, 2024
Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher DiseaseMary Kate LoPiccolo, Zerui Wang, Gadi Maayan Eshed, et al.
American Journal of Hematology|April 30, 2024
Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher RegistryPramod K Mistry, Manisha Balwani, Joel Charrow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2021
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's DiseaseMatthew Surface, Manisha Balwani, Cheryl Waters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2025
A Prospective, Blinded Study of Symptom Prevalence and Specificity of Porphyrin Precursors in Carriers of Acute Hepatic PorphyriaMohsen Merati, Nanditha Jayakumar, Yuvraaj Kapoor, et al.
Journal of Inherited Metabolic Disease|November 25, 2010
Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327RAlev Hasanoglu, Manisha Balwani, Ciğdem S Kasapkara, et al.
JIMD Reports|November 20, 2019
Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X-linked protoporphyriaHetanshi Naik, Jessica R Overbey, Robert J Desnick, et al.
JAMA Dermatology|June 15, 2017
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked ProtoporphyriaManisha Balwani, Hetanshi Naik, Karl E Anderson, et al.
Pageof 10